Royal London Asset Management LTD Regeneron Pharmaceuticals, Inc. Transaction History

Royal London Asset Management LTD

  • $39.4 Billion
  • Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 43,675 shares of REGN stock, worth $30.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
43,675
Previous 42,523 2.71%
Holding current value
$30.9 Million
Previous $44.7 Million 2.73%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $1.18 Million - $1.38 Million
1,152 Added 2.71%
43,675 $45.9 Million
Q2 2024

Aug 07, 2024
BUY
$883.2 - $1071.19 $1.29 Million - $1.57 Million
1,463 Added 3.56%
42,523 $44.7 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $531,684 - $585,083
-589 Reduced 1.41%
41,060 $39.5 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $827,892 - $941,655
1,068 Added 2.63%
41,649 $36.6 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $1.14 Million - $1.39 Million
1,652 Added 4.24%
40,581 $33.4 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $1.56 Million - $1.85 Million
2,231 Added 6.08%
38,929 $28 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $101,393 - $123,218
-149 Reduced 0.4%
36,698 $30.2 Million
Q4 2022

Feb 09, 2023
BUY
$705.89 - $766.39 $1.29 Million - $1.4 Million
1,824 Added 5.21%
36,847 $26.6 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $749,030 - $945,237
-1,305 Reduced 3.59%
35,023 $24.1 Million
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $173,278 - $233,473
316 Added 0.88%
36,328 $21.5 Million
Q1 2022

May 13, 2022
BUY
$595.12 - $698.43 $1.09 Million - $1.28 Million
1,830 Added 5.35%
36,012 $25.2 Million
Q4 2021

Oct 18, 2022
SELL
$543.48 - $670.97 $327,174 - $403,923
-602 Reduced 1.73%
34,182 $21.6 Million
Q4 2021

Jan 18, 2022
SELL
$543.48 - $670.97 $327,174 - $403,923
-602 Reduced 1.73%
34,182 $21.6 Million
Q3 2021

Oct 18, 2022
BUY
$574.03 - $680.96 $293,903 - $348,651
512 Added 1.49%
34,784 $21 Million
Q3 2021

Nov 02, 2021
BUY
$574.03 - $680.96 $293,903 - $348,651
512 Added 1.49%
34,784 $21 Million
Q2 2021

Oct 18, 2022
SELL
$472.8 - $558.54 $972,076 - $1.15 Million
-2,056 Reduced 5.66%
34,272 $19.1 Million
Q2 2021

Jul 14, 2021
SELL
$472.8 - $558.54 $878,462 - $1.04 Million
-1,858 Reduced 5.14%
34,272 $19.1 Million
Q1 2021

Oct 17, 2022
SELL
$446.73 - $548.2 $88,452 - $108,543
-198 Reduced 0.55%
36,130 $17.1 Million
Q1 2021

Apr 13, 2021
BUY
$446.73 - $548.2 $442,262 - $542,718
990 Added 2.82%
36,130 $17.1 Million
Q4 2020

Jan 29, 2021
SELL
$478.3 - $607.98 $1.09 Million - $1.38 Million
-2,271 Reduced 6.07%
35,140 $17 Million
Q3 2020

Nov 04, 2020
SELL
$544.75 - $658.21 $17,432 - $21,062
-32 Reduced 0.09%
37,411 $21.5 Million
Q2 2020

Jul 31, 2020
BUY
$493.32 - $643.92 $2.82 Million - $3.68 Million
5,722 Added 18.04%
37,443 $22.9 Million
Q1 2020

May 01, 2020
SELL
$336.18 - $494.43 $48,073 - $70,703
-143 Reduced 0.45%
31,721 $15 Million
Q4 2019

Feb 05, 2020
SELL
$274.13 - $376.51 $63,324 - $86,973
-231 Reduced 0.72%
31,864 $11.9 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $57,426 - $66,861
210 Added 0.66%
32,095 $8.9 Million
Q2 2019

Jul 31, 2019
SELL
$299.6 - $414.82 $116,544 - $161,364
-389 Reduced 1.21%
31,885 $9.98 Million
Q1 2019

Apr 30, 2019
SELL
$372.08 - $439.57 $641,465 - $757,818
-1,724 Reduced 5.07%
32,274 $0
Q4 2018

Jan 29, 2019
BUY
$335.82 - $403.04 $623,617 - $748,445
1,857 Added 5.78%
33,998 $12.3 Million
Q3 2018

Nov 08, 2018
SELL
$351.14 - $408.51 $526,358 - $612,356
-1,499 Reduced 4.46%
32,141 $0
Q2 2018

Sep 19, 2018
BUY
$284.6 - $344.99 $9.57 Million - $11.6 Million
33,640 New
33,640 $11.6 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email